| David Paul Schuetze, DO | |
|
10 Medical Park Dr, Asheville, NC 28803-2493 | |
| (828) 253-0762 | |
| (828) 586-8209 |
| Full Name | David Paul Schuetze |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 20 Years |
| Location | 10 Medical Park Dr, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437333135 | NPI | - | NPPES |
| 1571V | Other | NC | BCBS |
| 5915195 | Medicaid | NC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Park Ridge Health | Hendersonville, NC | Hospital |
| Transylvania Regional Hospital, Inc | Brevard, NC | Hospital |
| Angel Medical Center | Franklin, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain Area Pathology Pa | 2567490832 | 12 |
News Archive
DuPont announced it has reached a regulatory milestone and the final step of the U.S. regulatory process with confirmation from the United States Department of Agriculture that its Plenish high oleic soybean trait has been approved for cultivation in the United States.
When pregnant women need medications, there is often concern about possible effects on the fetus. Although some drugs are clearly recognized to cause birth defects, and others are generally recognized as safe, surprisingly little is known about most drugs' level of risk. Researchers in the Children's Hospital Boston Informatics Program have created a preclinical model for predicting a drug's teratogenicity based on characterizing the genes that it targets.
For patients with degenerative cervical myelopathy, imaging with 18F-FDG positron emission tomography (PET) could act as a marker for a potentially reversible phase of the disease in which substantial clinical improvement can be achieved.
Two newly released studies in the U.S. have to some extent come to conflicting results. According to one study, by researchers at Emory University, attempts over the last decade to address race and gender disparities in the treatment of U.S. patients hospitalized for heart attacks, still in some respects raise cause for concern.
› Verified 4 days ago
| Entity Name | Mountain Area Pathology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386600054 PECOS PAC ID: 2567490832 Enrollment ID: O20050728000314 |
News Archive
DuPont announced it has reached a regulatory milestone and the final step of the U.S. regulatory process with confirmation from the United States Department of Agriculture that its Plenish high oleic soybean trait has been approved for cultivation in the United States.
When pregnant women need medications, there is often concern about possible effects on the fetus. Although some drugs are clearly recognized to cause birth defects, and others are generally recognized as safe, surprisingly little is known about most drugs' level of risk. Researchers in the Children's Hospital Boston Informatics Program have created a preclinical model for predicting a drug's teratogenicity based on characterizing the genes that it targets.
For patients with degenerative cervical myelopathy, imaging with 18F-FDG positron emission tomography (PET) could act as a marker for a potentially reversible phase of the disease in which substantial clinical improvement can be achieved.
Two newly released studies in the U.S. have to some extent come to conflicting results. According to one study, by researchers at Emory University, attempts over the last decade to address race and gender disparities in the treatment of U.S. patients hospitalized for heart attacks, still in some respects raise cause for concern.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Paul Schuetze, DO Po Box 419, Sylva, NC 28779-0419 Ph: (828) 253-0762 | David Paul Schuetze, DO 10 Medical Park Dr, Asheville, NC 28803-2493 Ph: (828) 253-0762 |
News Archive
DuPont announced it has reached a regulatory milestone and the final step of the U.S. regulatory process with confirmation from the United States Department of Agriculture that its Plenish high oleic soybean trait has been approved for cultivation in the United States.
When pregnant women need medications, there is often concern about possible effects on the fetus. Although some drugs are clearly recognized to cause birth defects, and others are generally recognized as safe, surprisingly little is known about most drugs' level of risk. Researchers in the Children's Hospital Boston Informatics Program have created a preclinical model for predicting a drug's teratogenicity based on characterizing the genes that it targets.
For patients with degenerative cervical myelopathy, imaging with 18F-FDG positron emission tomography (PET) could act as a marker for a potentially reversible phase of the disease in which substantial clinical improvement can be achieved.
Two newly released studies in the U.S. have to some extent come to conflicting results. According to one study, by researchers at Emory University, attempts over the last decade to address race and gender disparities in the treatment of U.S. patients hospitalized for heart attacks, still in some respects raise cause for concern.
› Verified 4 days ago
Dr. Jeffrey Ross Embrey, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 10 Medical Park Dr, Asheville, NC 28803 Phone: 828-210-1792 | |
Joseph Patrick Sleater, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Pathology Dept, Asheville, NC 28801 Phone: 828-253-0762 Fax: 828-254-4892 | |
Harold Chalmers Poston Jr., MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Pathology Dept, Asheville, NC 28801 Phone: 828-253-0763 | |
Richard L Landau, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 509 Biltmore Ave, Pathology Dept, Asheville, NC 28801 Phone: 828-253-0763 | |
Doreen C Griswold, MD Pathology Medicare: Medicare Enrolled Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 | |
Stacey Lynn Neal, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Pathology Dept, Asheville, NC 28801 Phone: 828-253-0763 | |
Meryl Levya Goldstein, MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-253-0762 Fax: 828-254-4892 |